Device Trial Radar · NCT00407147
Procalcitonin Level to Discontinue Antibiotics on ICU Patients With no Obvious Site of Infection
Last checked: Nov 19, 2026Latest source record: Jan 18, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
11
Actual
Start
Jul 2008
Primary completion
Jun 2009
Study completion Jun 2009
Sponsor
- Lead sponsor
- Brahms AGNot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 4, 2006
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to test whether a U.S. Food and Drug Administration (FDA) approved laboratory test (PCT Kryptor) can help doctors make better decisions on the need for antibiotic therapy in ICU patients with suspected infections.
Conditions
- Infection
- Bacterial Infection
- Sepsis
Interventions
Procalcitonin assay - B.R.A.H.M.S PCT sensitive KryptorDevice
antibiotic treatment based on clinical decision making with "traditional thought processes" used in both groups. In addition the physician will be given access to Procalcitonin values with recommended thresholds for likelihood of infection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Days on antibiotics beginning with day 4 until the first day without antibiotics (up to max. 28 days follow up)Time frame: 28 days
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Saint Louis University - medical intensive care unit
St Louis, Missouri
Cooper University Hospital
Camden, New Jersey
Rhode Island Hospital
Providence, Rhode Island
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.